Article | May 20, 2016

Developing Immunotherapies For Cell-Based Vs. Non Cell-Based Therapies

Source: Thermo Fisher Scientific
Developing Immunotherapies For Cell-Based Vs. Non Cell-Based Therapies

By Dan O'Donnell, Area Director of Cell Therapy Logistics

Immunotherapies harness the power of the body’s own defense mechanism, the immune system, to combat disease. They were initially introduced in the form of non cell-based biologics and vaccines, such as the splurge of products known as the check-point inhibitors designed to target the PD1/PD-L1 immune pathway. An individual would be injected with a weakened form of a virus, exposing the body to the disease and prompting the immune system to produce antibodies to fight the infection from the live virus.